• We assessed the effect of acteoside, a naturally occurring antioxidative phenylethanoid, on hepatic apoptosis and the subsequent liver failure induced by D-Galactosamine (D-GalN) and lipopolysaccharide (LPS). (elsevierpure.com)
  • The purpose of this study was to investigate the effects of fetuin-A on d-galactosamine/lipopolysaccharide (d-GalN/LPS)-induced liver failure in mice. (hofstra.edu)
  • Succinate dehydrogenase inhibitor dimethyl malonate alleviates LPS/d-galactosamine-induced acute hepatic damage in mice. (nih.gov)
  • Methods: An acute rat liver injury model induced by D-galactosamine was used. (bvsalud.org)
  • Galactosamine is a hexosamine derived from galactose with the molecular formula C6H13NO5. (wikipedia.org)
  • In the Leloir pathway galactosamine is metabolized into galactosamine-1-phosphate (by galactokinase) and UDP-galactosamine (by UDP-galactose uridyltransferase). (wikipedia.org)
  • The E histolytica galactose/ N -acetyl-D-galactosamine (Gal/GalNAc) lectin is an adhesion protein complex that sustains tissue invasion. (medscape.com)
  • Galactosamine is a hepatotoxic, or liver-damaging, agent that is sometimes used in animal models of liver failure. (wikipedia.org)
  • Galactosamine is used to induce hepatitis in rodent liver for research purposes. (wikipedia.org)
  • The result of using galactosamine to induce hepatitis is a disease model in which there is necrosis and inflammation of the liver. (wikipedia.org)
  • This type of tissue damage triggered by galactosamine resembles drug-induced liver disease in humans. (wikipedia.org)
  • Another recent hypothesis states that overexpression of pro-inflammatory cytokines (such as tumor necrosis factor (TNFα) and NFκB-dependent inducible nitric oxide synthase (iNOS) over expression play a role in galactosamine-induced damage to liver cells. (wikipedia.org)
  • This study explored the effects of a classical Chinese medicine formula- Xiao-Chai-Hu Tang(XCHT) on the model mice with D-galactosamine -induced liver injury. (nih.gov)
  • It may be through decreasing the serum IL-6 and TNF-α levels and FasmRNA, FasLmRNA, Bax protein expression and increasing the Bcl-2 mRNA expression of the liver tissues that XCHT significantly relieved the D-galactosamine -induced liver injury. (nih.gov)
  • In 1976, the enzyme deficiency in Morquio syndrome type IVA (galactosamine-6-sulfatase deficiency [ie, N -acetyl-galactosamine-6-sulfate sulfatase deficiency]) was identified. (medscape.com)
  • Wogonin pretreatment prevented the lethal shock in mice injected with D-galactosamine (D-GaIN) and LPS, but not in mice injected with a high dose of LPS. (fujita-hu.ac.jp)
  • A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates. (nih.gov)
  • Based on a literature review very few articles have been published on N-Acetyl-D-galactosamine 1-phosphate. (hmdb.ca)
  • N-Acetyl-D-galactosamine 1-phosphate belongs to the class of organic compounds known as n-acyl-alpha-hexosamines. (hmdb.ca)
  • Only HPA, which is specific for N-acetyl-galactosamine (GalNAc), bound to the midgut. (nih.gov)
  • The E histolytica galactose/ N -acetyl-D-galactosamine (Gal/GalNAc) lectin is an adhesion protein complex that sustains tissue invasion. (medscape.com)
  • The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each diastereomer in LEQVIO through stereo chemically controlled synthesis and biological activity assessment using in vitro and animal models. (nih.gov)
  • Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury. (bvsalud.org)
  • In this study, we aimed to investigate the protective effects of S. boulardii on D- Galactosamine -induced liver injury in mice . (bvsalud.org)
  • Hepatic cysteamine and non-protein sulfhydryl (NPSH) levels were determined in galactosamine (GAL)-poisoned rats following hepatoprotective cystamine or cysteamine treatments to determine whether alterations of hepatic NPSH status could contribute to their observed protective actions. (nih.gov)
  • This type of tissue damage triggered by galactosamine resembles drug-induced liver disease in humans. (wikipedia.org)
  • 4. Galactosamine is an inducer of Gal genes in Saccharomyces cerevisiae. (nih.gov)
  • ALF was induced by the intraperitoneal injection of D-galactosamine (D-GalN) in experimental rats, who then received either sham (ALF), manual acupuncture (MA), electroacupuncture (EA), or silymarin (PC, positive control) treatment. (hindawi.com)
  • Hepatic cysteamine and non-protein sulfhydryl levels following cystamine or cysteamine treatment of galactosamine-poisoned rats. (nih.gov)
  • D(+)-Galactosamine HC1 (400 mg/kg, ip) was administered to male Sprague-Dawley rats at 8 pm. (nih.gov)
  • Another recent hypothesis states that overexpression of pro-inflammatory cytokines (such as tumor necrosis factor (TNFα) and NFκB-dependent inducible nitric oxide synthase (iNOS) over expression play a role in galactosamine-induced damage to liver cells. (wikipedia.org)
  • The result of using galactosamine to induce hepatitis is a disease model in which there is necrosis and inflammation of the liver. (wikipedia.org)